Prothelia
Milford · Founded 2007
About Prothelia
Prothelia is a US based private biotech company founded in 2007. Prothelia’s lead program is a novel protein therapy for the treatment of congenital muscular dystrophy type 1A, a rare disease affecting approximately 4,000 patients.
Company Facts
- Founded: 2007
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Jun 2020)
- Website: prothelia.com
- Phone: 508-561-9298
Social Profiles
Canonical: https://fsome.com/organization/prothelia-8440888 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.